Diana Antunes

Dr. Diana Antunes

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PCPedro Silva Cunha
Pedro Silva Cunha
DADiana Antunes
Diana Antunes
SLSérgio Laranjo
Sérgio Laranjo
ACAna Coutinho
Ana Coutinho
JAJoão Abecasis
João Abecasis
MOMário Martins Oliveira
Mário Martins Oliveira
Early-onset atrial fibrillation (AF) can be the manifestation of a genetic atrial myopathy. However, specific genetic identification of a mutation causing atrial fibrosis is rare. We report a case of a young patient with an asymptomatic AF, diagnosed during a routine examination. The cardiac MRI revealed extensive atrial fibrosis and the electrophysiology study showed extensive areas of low voltage. The genetic investigation identified a homozygous pathogenic variant in the NPPA gene in the index case and the presence of the variant in heterozygosity in both parents.

Verified
Journal Article
Open access
PDF file
MMMafalda Santos Melo
Mafalda Santos Melo
MRMariana Ribeiro
Mariana Ribeiro
Paulo Filipe SilvaPaulo Filipe Silva
Paulo Filipe Silva
SVSusana Valente
Susana Valente
FAFilipe da Costa Alves
Filipe da Costa Alves
JOJorge Oliveira
Jorge Oliveira
The application of whole-exome sequencing (WES) for diagnostic purposes has the potential to unravel secondary findings unrelated with the primary reason of testing. Some of those might be of high clinical utility and comprise disease-causing variants in genes, related to life-threatening and clinically actionable diseases. Clarifying the allelic frequencies of such variants in specific populations is a crucial step for the large-scale deployment of genomic medicine. We analysed medically relevant variants in the 81 genes from the American College of Medical Genetics and Genomics (ACMG) v3.2 list of actionable loci, using WES data from a diagnostic laboratory cohort of 3972 persons, tentatively resampled to represent the Portuguese population geographic distribution. We identified medically actionable variants in 6.2% of our cohort, distributed across several disease domains: cardiovascular disorders (3.0%), cancer predisposition (2.0%), miscellaneous disorders (1.1%), and metabolic disorders (0.1%). Additionally, we estimated a frequency of heterozygotes for recessive disease alleles of 11.1%. Overall, our results suggest that medically actionable findings can be identified in approximately 6.2% of persons from our population. This is the first study estimating medically actionable findings in Portugal. These results provide valuable insight for patients, healthcare providers, and policymakers involved in advancing genomic medicine at the national and international level.

21 March 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
MMMafalda Santos Melo
Mafalda Santos Melo
Jorge M. A. OliveiraJorge M. A. Oliveira
Jorge M. A. Oliveira
DADiana Antunes
Diana Antunes

23 October 2023 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
PBPedro Garcia Brás
Pedro Garcia Brás
ICIsabel Cardoso
Isabel Cardoso
JVJosé Miguel Viegas
José Miguel Viegas
DADiana Antunes
Diana Antunes
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
Arrhythmogenic cardiomyopathy (ACM) may present with sudden cardiac arrest (SCA), and demonstration of a pathogenic variant in ACM-related genes is crucial for its definitive diagnosis. A 42-year-old female patient with family history of sudden cardiac death (SCD) was referred to the cardiomyopathy clinic after two episodes of aborted SCA. In the second episode, the patient was transported under cardiopulmonary resuscitation (downtime of 57 min) until extracorporeal membrane oxygenation was implanted. A thorough diagnostic work-up led to a diagnosis of biventricular ACM. Genetic testing revealed a previously undescribed variant in ACM patients in the MYH6 gene, c.3673G>T p.(Glu 1225*), which inserts a premature stop codon. This was considered a possible pathogenic variant originating a truncated protein, previously undescribed in ACM. The patient’s 23-year-old daughter was positive for the MYH6 variant and had ECG abnormalities suggestive of ACM. This case details the complex differential diagnosis of SCA and explores the current recommendations for the diagnosis of biventricular ACM. The identification of a MYH6 variant in a patient with ACM, recurrent SCA, and family history of SCD appears to support the hypothesis of the pathogenicity of MYH6 variants in ACM, in which the association of phenotype with sarcomere variants is still unclear.

15 October 2025 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
MCMafalda Cabral
Mafalda Cabral
FCFrancisco Branco Caetano
Francisco Branco Caetano
CCCarla Conceição
Carla Conceição
DADiana Antunes
Diana Antunes
LLLurdes Lopes
Lurdes Lopes
Complex diseases arise from the interplay of genetic and environmental factors. We present a case where complex diseases seem to coexist. A 12-month-old girl was referred for short stature and hypotonia. Initial evaluation revealed central hypothyroidism, growth hormone deficiency and a small pituitary gland with ectopic neurohypophysis. Replacement therapy improved growth, but developmental delay and strabismus ensued. At age 10, she experienced a first seizure treated with levetiracetam. At age 12, she presented diabetic ketoacidosis and functional insulin therapy was started; positive autoantibodies confirmed autoimmune etiology. Initial genetic testing performed by microarray analysis retrieved normal results, but exome sequencing revealed a heterozygous pathogenic variant in KANSL1 gene, allowing for the diagnosis of Koolen-de Vries syndrome. In this patient, Koolen-de Vries syndrome presented initially as hypopituitarism and only later epilepsy. Afterwards, type 1 diabetes mellitus ensued, highlighting the complexity of intertwined conditions.

17 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MMMafalda Santos Melo
Mafalda Santos Melo
MRMariana Ribeiro
Mariana Ribeiro
Paulo Filipe SilvaPaulo Filipe Silva
Paulo Filipe Silva
SVSusana Valente
Susana Valente
FAFilipe da Costa Alves
Filipe da Costa Alves
JOJorge Oliveira
Jorge Oliveira
The application of whole-exome sequencing (WES) for diagnostic purposes has the potential to unravel secondary findings unrelated with the primary reason of testing. Some of those might be of high clinical utility and comprise disease-causing variants in genes, related to lifethreatening and clinically actionable diseases. Clarifying the allelic frequencies of such variants in specific populations is a crucial step for the large-scale deployment of genomic medicine. We analysed medically relevant variants in the 81 genes from the American College of Medical Genetics and Genomics (ACMG) v3.2 list of actionable loci, using WES data from a diagnostic laboratory cohort of 3,972 persons, tentatively resampled to represent the Portuguese population geographic distribution. We identified medically actionable variants in 6.2% of our cohort, distributed across several disease domains: cardiovascular disorders (3.0%), cancer predisposition (2.0%), miscellaneous disorders (1.1%), and metabolic disorders (0.1%). Additionally, we estimated a frequency of heterozygotes for recessive disease alleles of 11.1%. Overall, our results suggest that medically actionable findings can be identified in approximately 6.2% of persons from our population. This is the first study estimating medically actionable findings in Portugal. These results provide valuable insight for patients, healthcare providers, and policymakers involved in advancing genomic medicine at the national and international level.